Skip to main content

Comparative Study of the Free Lipids of Eight BCG Daughter Strains

  • Conference paper
Investigation and Stimulation of Immunity in Cancer Patients

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 47))

Abstract

BCG is widely used for vaccination against tuberculosis and this is its primary use. The initial strain of Calmette and Guérin has been maintained in many laboratories for more than 40 years during which time the original BCG strain has undergone some genotypic changes that are noticeable in vitro as well in animal tests and in man [6]. There are now some dozens of BCG daughter strains, differing in particular in the degree of attenuation [5]. It is difficult to compare these daughter strains and to evaluate their immunogenic properties [6].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aebi, A., Asselineau, J., Lederer, E.: Sur les lipides de la souche Brévannes de Mycobacterium tuberculosis. Bull. Soc. Chim. biol. (Paris) 35, 661 (1953).

    CAS  Google Scholar 

  2. Asselineau, J.: The bacterial lipids. Paris: Hermann. San Francisco: Holden-Day 1966.

    Google Scholar 

  3. Asselineau, J., Buc, H., Jolles, P.: Lederer, E.: Sur la structure chimique d’une fraction peptido-glycolipidique (cires D) isolée de Mycobacterium tuberculosis var. bominis. Bull. Soc. Chico. biol. (Paris) 40, 1953 (1958).

    CAS  Google Scholar 

  4. Bekierkunst, A., Levij, I. S., Yarkoni, E., Vilkas, E., Lederer, E.: Suppression of urethane-induced lung adenomas in mice treated with trehalose-6,6’-dimycolate (cord factor) and living Bacillus Calmette-Guérin. Science 174, 1240 (1971).

    Article  PubMed  CAS  Google Scholar 

  5. Dubos, R. J.: Biochemical determinants of microbial diseases, p. 97. Cambridge, Mass.: Harvard University Press 1954.

    Google Scholar 

  6. Frappier, A., Portelance, V., ST. Pierre, J., Panisset, M.: Conference on immunization in tuberculosis. Progress to date and future trends and research needs. Washington 1971.

    Google Scholar 

  7. Goren, M. B.: Mycobacterial lipids: selected topic •sBact. Rev. 36, 33 (1972).

    CAS  Google Scholar 

  8. Hiu, I. J., Amiel, J. L.: Isolation of immunological adjuvant component from BCG cells. Rev. Europ. Etud. clin. biol. 16, 55 (1971).

    CAS  Google Scholar 

  9. Hiu, I. J., Amiel, J. L., Nikdjon, K.: Immunochemical study of mycobacteria firmly bound lipids. Rev. Europ. Etud. clin. biol. 15, 887 (1970).

    CAS  Google Scholar 

  10. Lemonde, P., Clode, M.: Effect of BCG infection on leukemia and polyoma in mice and hamsters. Proc. Soc. exp. Biol. (N.Y.) 111, 739 (1962).

    CAS  Google Scholar 

  11. Lemonde, P., Clore, M.: Influence of Bacillus Calmette-Guérin infection on polyoma in hamsters and mice. Cancer Res. 26, 585 (1966).

    PubMed  CAS  Google Scholar 

  12. Markovits, J., Vilkas, E., Lederer, E.: Sur la Structure des cires D, peptidoglycolipides macromoléculaires des souches humaines de Mycobacterium tuberculosis. Europ. J. Biochem. 18, 287 (1971).

    Article  PubMed  CAS  Google Scholar 

  13. Mathé, G.: Active immunotherapy of leukemia L-1210 administered after tumor grafting. Rev. franc. Etud. clin. biol. 13, 881 (1968).

    PubMed  Google Scholar 

  14. Pigretti, M., Vilkas, E., Lederer, E., Bloch, H.: Propriétés chimiques et biologiques de fractions phosphatidiques isolées de l’antigène méthylique de Mycobacterium tuberculosis. Bull. Soc. Chim. biol. (Paris) 47, 2039 (1965).

    CAS  Google Scholar 

  15. Portelance, V., Asselineau, J.: Non-phosphorus contaminants of mycobacterial phospholipid preparations. Amer. R v. resp. Dis. 103, 853 (1971).

    CAS  Google Scholar 

  16. Promé, J. C., Lacave, C., Laneelle, M A Sur les structures des lipides à ornithine de Brucella melitensis et de Mycobacterium bovis (BCG). C.R. Acad. Sci. (Paris), Ser. C 269, 1664 (1969).

    Google Scholar 

  17. Reif, A. E., Kim, C. A. H.: Leukemia L-1210 therapy trials with antileukemia serum and Bacillus Calmette-Guérin. Cancer Res. 31, 1606 (1971).

    PubMed  CAS  Google Scholar 

  18. White, R. G., Jolles, P., Samour, D., Lederer, E.: Correlation of adjuvant activity and chemical structure of wax D fractions of Mycobacteria. Immunology 7, 158 (1964).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1974 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Asselineau, J., Portelance, V. (1974). Comparative Study of the Free Lipids of Eight BCG Daughter Strains. In: Mathé, G., Weiner, R. (eds) Investigation and Stimulation of Immunity in Cancer Patients. Recent Results in Cancer Research, vol 47. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-49284-6_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-49284-6_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-49286-0

  • Online ISBN: 978-3-642-49284-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics